Real-world outcomes in patients with malignancy and moderate-to-severe psoriasis treated with guselkumabCapsule Summary

• Váldodahkkit: Tamara Gracia Cazaña, MD, PhD (Dahkki), Josep Riera Monroig, MD (Dahkki), Rosa Izu, MD, PhD (Dahkki), Ignacio Yanguas, MD, PhD (Dahkki), Marta Lorda Espés, MD, PhD (Dahkki), María Pilar Sánchez Salas, MD (Dahkki), Miguel Fernando García Gil, MD (Dahkki), Alba Navarro Bielsa, MD (Dahkki), Beatriz Aldea Manrique, MD (Dahkki), Manuel Almenara Blasco, MD (Dahkki), Francisco Javier García-Latasa de Araníbar, MD, PhD (Dahkki), Victoria Fuentelsaz, MD, PhD (Dahkki), Ana Morales Callaghan, MD, PhD (Dahkki), Mariano Ara-Martín, MD, PhD (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Elsevier, 2024-09-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background: The treatment of psoriasis in patients with a personal history of cancer is a matter of debate and limited evidence is available to guide clinicians. Objectives: To report a multicenter real-life experience of a group of patients with psoriasis undergoing treatment with guselkumab and a...